Received:26 July 2019,
Published:25 December 2019
移动端阅览
Lei MAO, Bing XIA, Chen TIAN, et al. Incidence and risk factors for
Lei MAO, Bing XIA, Chen TIAN, et al. Incidence and risk factors for
Objective
2
To investigate the incidence and risk factors for
Clostridium difficile
infection (CDI) in patients with diarrhea during autologous hematopoietic stem cell transplantat
ion (auto-HSCT) and provide guidance for clinical diagnosis and treatment.
Methods
2
Clinical data of patients with diarrhea during auto-HSCT between May 2005 and July 2019 were collected and retrospectively analyzed. The patients with positive results of
Clostridium difficile
anaerobic culture and
Clostridium difficile
toxin A/B test were assigned into the CDI group
and the others were into the non-CDI group. The incidence and risk factors for CDI were analyzed in this case-control study.
Results
2
A total of 202 patients developed diarrhea during auto-HSCT in this study. Thirty-three patients suffered from CDI
with an incidence rate of 16.3% and a median onset of 12(8~17) d since the admission of transplantation ward. The results of the univariate analysis indicated that the incidence of CDI was associated with the administration of busulfan
bortezomib and carmustine (all
P
<
0.05). The multivariate analysis showed that busulfan and bortezomib were the independent risk factors for CDI (all
P
<
0.05). The median time of diarrhea was 6(4~9) d in CDI patients
and 2 patients (6.0%) developed septic shock and died.
Conclusion
2
The incidence rate of CDI is quite high in the patients with diarrhea during auto-HSCT. The administration of busulfan and bortezomib are risk factors for CDI.
BANAEI N ANIKST V SCHROEDER L F Burden of Clostridium difficile infection in the United States N Engl J Med 2015 372 24 2368 2369 10.1056/NEJMc1505190 BANAEI N, ANIKST V, SCHROEDER L F. Burden of Clostridium difficile infection in the United States[J ] . N Engl J Med, 2015, 372(24): 2368-2369. DOI:10.1056/NEJMc1505190.
SALAMONOWICZ M OCIEPA T FRACZKIEWICZ J Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation Eur J Clin Microbiol Infect Dis 2018 37 9 1805 1812 10.1007/s10096-018-3316-5 SALAMONOWICZ M, OCIEPA T, FRACZKIEWICZ J, et al . Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation[J ] . Eur J Clin Microbiol Infect Dis, 2018, 37(9): 1805-1812. DOI:10.1007/s10096-018-3316-5.
LAVALLÉE C LABBÉ A C TALBOT J D Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada Transpl Infect Dis 2017 19 1 e12648 10.1111/tid.12648 LAVALLÉE C, LABBÉ A C, TALBOT J D, et al . Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada[J ] . Transpl Infect Dis, 2017, 19(1): e12648. DOI:10.1111/tid.12648.
ILETT E E HELLEBERG M REEKIE J Incidence rates and risk factors of Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients Open Forum Infect Dis 2019 6 4 ofz086 10.1093/ofid/ofz086 ILETT E E, HELLEBERG M, REEKIE J, et al . Incidence rates and risk factors of Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients[J ] . Open Forum Infect Dis, 2019, 6(4): ofz086. DOI:10.1093/ofid/ofz086.
廖 亚龙 侯 铁英 邵 裕燊 艰难梭菌感染临床特征与危险因素分析 中华医院感染学杂志 2016 26 21 4837 4840 10.11816/cn.ni.2016-153850 廖亚龙, 侯铁英, 邵裕燊, 等.艰难梭菌感染临床特征与危险因素分析[J].中华医院感染学杂志, 2016, 26(21): 4837-4840. DOI:10.11816/cn.ni.2016-153850
LIAO Y L HOU T Y SHAO Y S Clinical characteristics of Clostridium difficile infections and risk factors Chin J Nosocomiol 2016 26 21 4837 4840 10.11816/cn.ni.2016-153850 LIAO Y L, HOU T Y, SHAO Y S, et al . Clinical characteristics of Clostridium difficile infections and risk factors[J ] . Chin J Nosocomiol, 2016, 26(21): 4837-4840. DOI:10.11816/cn.ni.2016-153850.
金 利民 沈 宇泓 曹 晨曦 恶性肿瘤患者艰难梭菌感染相关性腹泻的临床特征分析 中华全科医学 2018 16 5 820 822, 834 10.16766/j.cnki.issn.1674-4152.000224 金利民, 沈宇泓, 曹晨曦, 等.恶性肿瘤患者艰难梭菌感染相关性腹泻的临床特征分析[J].中华全科医学, 2018, 16(5): 820-822, 834. DOI:10.16766/j.cnki.issn.1674-4152.000224.
JIN L M SHEN Y H CAO C X Clinical characteristics for Clostridium difficile -associated diarrhea among malignant tumor patients Chin J Gen Pract 2018 16 5 820 822, 834 10.16766/j.cnki.issn.1674-4152.000224 JIN L M, SHEN Y H, CAO C X, et al . Clinical characteristics for Clostridium difficile -associated diarrhea among malignant tumor patients[J ] . Chin J Gen Pract, 2018, 16(5): 820-822, 834. DOI:10.16766/j.cnki.issn.1674-4152.000224.
李 来 王 洋 朱 婉 ICU艰难梭菌感染及其影响因素分析 中华医院感染学杂志 2019 29 13 1940 1944 10.11816/cn.ni.2019-190703 李来, 王洋, 朱婉, 等. ICU艰难梭菌感染及其影响因素分析[J].中华医院感染学杂志, 2019, 29(13): 1940-1944. DOI:10.11816/cn.ni.2019-190703.
LI L WANG Y ZHU W Influencing factors for Clostridium difficile infection in ICU Chin J Nosocomiol 2019 29 13 1940 1944 10.11816/cn.ni.2019-190703 LI L, WANG Y, ZHU W, et al . Influencing factors for Clostridium difficile infection in ICU[J ] . Chin J Nosocomiol, 2019; 29(13): 1940-1944. DOI:10.11816/cn.ni.2019-190703.
MCDONALD L C GERDING D N JOHNSON S Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA) Clin Infect Dis 2018 66 7 987 994 10.1093/cid/ciy149 MCDONALD L C, GERDING D N, JOHNSON S, et al . Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)[J ] . Clin Infect Dis, 2018, 66(7): 987-994. DOI:10.1093/cid/ciy149.
中华预防医学会医院感染控制分会 中国艰难梭菌医院感染预防与控制指南 中华医院感染学杂志 2018 28 23 3674 3680 10.11816/cn.ni.2018-183451 中华预防医学会医院感染控制分会.中国艰难梭菌医院感染预防与控制指南[J].中华医院感染学杂志, 2018, 28(23): 3674-3680. DOI:10.11816/cn.ni.2018-183451.
Chinese Association for Hospital Infection Control Guidelines for the prevention and control of Clostridium difficile nosocomial infection in China Chin J Nosocomiol 2018 28 23 3674 3680 10.11816/cn.ni.2018-183451 Chinese Association for Hospital Infection Control. Guidelines for the prevention and control of Clostridium difficile nosocomial infection in China[J ] . Chin J Nosocomiol, 2018, 28(23): 3674-3680. DOI:10.11816/cn.ni.2018-183451.
谢 和宾 曾 鸿 尹 柯 我国住院腹泻患者艰难梭菌感染率的荟萃分析 中华医院感染学杂志 2017 27 5 961 964 10.11816/cn.ni.2016-163019 谢和宾, 曾鸿, 尹柯, 等.我国住院腹泻患者艰难梭菌感染率的荟萃分析[J].中华医院感染学杂志, 2017, 27(5): 961-964. DOI:10.11816/cn.ni.2016-163019.
XIE H B ZENG H YIN K Prevalence rate of Clostridium difficile infection in hospitalized patients with diarrhea in China: a meta-analysis Chin J Nosocomiol 2017 27 5 961 964 10.11816/cn.ni.2016-163019 XIE H B, ZENG H, YIN K, et al . Prevalence rate of Clostridium difficile infection in hospitalized patients with diarrhea in China: a meta-analy sis[J ] . Chin J Nosocomiol, 2017, 27(5): 961-964. DOI:10.11816/cn.ni.2016-163019.
李 曙光 张 菲菲 刘 井波 北京一所教学医院艰难梭菌感染分析 中华医院感染学杂志 2017 27 19 4352 4355 10.11816/cn.ni.2017-170632 李曙光, 张菲菲, 刘井波, 等.北京一所教学医院艰难梭菌感染分析[J].中华医院感染学杂志, 2017, 27(19): 4352-4355. DOI:10.11816/cn.ni.2017-170632.
LI S G ZHANG F F LIU J B Analysis of Clostridium difficile infection in a teaching hospital in Beijing Chin J Nosocomiol 2017 27 19 4352 4355 10.11816/cn.ni.2017-170632 LI S G, ZHANG F F, LIU J B, et al . Analysis of Clostridium difficile infection in a teaching hospital in Beijing[J ] . Chin J Nosocomiol, 2017, 27(19): 4352-4355. DOI:10.11816/cn.ni.2017-170632.
龙 海燕 冯 萍 抗生素相关性腹泻患者艰难梭菌和白色念珠菌检测与临床特征分析 华西医学 2018 33 5 555 560 10.7507/1002-0179.201610067 龙海燕, 冯萍.抗生素相关性腹泻患者艰难梭菌和白色念珠菌检测与临床特征分析[J].华西医学, 2018, 33(5): 555-560. DOI:10.7507/1002-0179.201610067.
LONG H Y FENG P The investigation of toxin-producing Clostridium difficile and Candida albicans in the patients with antibiotic-associated diarrhea West China Med J 2018 33 5 555 560 10.7507/1002-0179.201610067 LONG H Y, FENG P. The investigation of toxin-producing Clostridium difficile and Candida albicans in the patients with antibiotic-associated diarrhea[J ] . West China Med J, 2018, 33(5): 555-560. DOI:10.7507/1002-0179.201610067.
BRUMINHENT J WANG Z X HU C Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation Biol Blood Marrow Transplant 2014 20 9 1329 1334 10.1016/j.bbmt.2014.04.026 BRUMINHENT J, WANG Z X, HU C, et al . Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation[J ] . Biol Blood Marrow Transplant, 2014, 20(9): 1329-1334. DOI:10.1016/j.bbmt.2014.04.026.
DUBBERKE E R RESKE K A OLSEN M A Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients Transpl Infect Dis 2018 20 2 e12855 10.1111/tid.12855 DUBBERKE E R, RESKE K A, OLSEN M A, et al . Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients[J ] . Transpl Infect Dis, 2018, 20(2): e12855. DOI:10.1111/tid.12855.
程 敬伟 刘 文恩 马 小军 中国成人艰难梭菌感染诊断和治疗专家共识 协和医学杂志 2017 8 Z1 131 138 10.3969/j.issn.1674-9081.2017.03.010 程敬伟, 刘文恩, 马小军, 等.中国成人艰难梭菌感染诊断和治疗专家共识[J].协和医学杂志, 2017, 8(Z1): 131-138. DOI:10.3969 /j.issn. 1674-9081.2017.03.010.
CHENG J W LIU W E MA X J Expert consensus on diagnosis and treatment of C. difficile infection in Chinese adults Med J Peking Union Med Coll Hosp 2017 8 Z1 131 138 10.3969/j.issn.1674-9081.2017.03.010 CHENG J W, LIU W E, MA X J, et al . Expert consensus on diagnosis and treatment of C. difficile infection in Chinese adults[J ] . Med J Peking Union Med Coll Hosp, 2017, 8(Z1): 131-138. DOI: 10.3969/j.issn.1674-9081.2017.03.010.
SHAH N N MCCLELLAN W FLOWERS C R Evaluating risk factors for Clostridium difficile infection in stem cell transplant recipients: A national study Infect Control Hosp Epidemiol 2017 38 6 651 657 10.1017/ice.2017.12 SHAH N N, MCCLELLAN W, FLOWERS C R, et al . Evaluating risk factors for Clostridium difficile infection in stem cell transplant recipients: A national study[J ] . Infect Co ntrol Hosp Epidemiol, 2017, 38(6): 651-657. DOI:10.1017/ice.2017.12.
HASSOUN A . Clostridium difficile associated disease [J ] . BMJ , 2018 : k4369 . DOI: 10.1136/bmj.k4369 . HASSOUN A. Clostridium difficile associated disease[J ] . BMJ, 2018: k4369. DOI: 10.1136/bmj.k4369.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
